GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly gaining a significant focus in therapeutic research, largely due to its notable impact on controlling diseases such as type 2 diabetes and excess body fat. Ongoing studies have revealed that more than glucose control, GLP-1 ag